Press release
3D Bioprinting Market for Tissues & Organs to Reach USD 6 Billion by 2035, Driven by Regenerative Medicine and Inkjet Bioprinting Advances
3D Bioprinting Market for Tissues & Organs to Reach USD 6 Billion by 2035, Driven by Regenerative Medicine and Inkjet Bioprinting
Growth is fueled by increasing demand for organ transplants, advances in regenerative medicine, and adoption of bioprinted models for pharmaceutical testing.
MarketGenics highlights 3D bioprinting as a transformative enabler in healthcare, offering alternatives to donor shortages, accelerating drug discovery, and unlocking personalized medicine.
Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the 3D Bioprinting Market Research Report: https://marketgenics.co/press-releases/3d-bioprinting-market-for-tissue-organs-11103
Recent Developments Shaping the Market
FDA Clearance for Bioabsorbable Nerve Implant
In June 2025, 3D Systems and TISSIUM received FDA clearance for COAPTIUM CONNECT, a 3D-printed bioabsorbable nerve implant enabling sutureless peripheral nerve repair. This milestone demonstrates the regulatory momentum behind clinically viable bioprinted solutions.
Scaffold-Free Innovation with Kenzan Bioprinter
In September 2024, Cyfuse Biosystems launched the Kenzan bioprinter, a scaffold-free platform that places cell spheroids precisely using needle arrays. The innovation accelerates vascularized tissue model fabrication, enabling more natural tissue maturation without synthetic scaffolds.
Advances in Personalized Therapeutics
By early 2024, companies like Organovo and CELLINK advanced applications for patient-specific skin, cartilage, and liver tissues, expanding beyond research into real medical use cases such as burn treatment, drug toxicity studies, and tissue regeneration.
Market Forecast to 2035
The 3D bioprinting market is set to create an incremental opportunity of USD 4.6 billion between 2025 and 2035.
North America will remain the largest and most mature market due to NIH-backed research, strong biotech ecosystems, and demand for transplant alternatives.
Asia-Pacific will register the fastest growth, supported by emerging biotech hubs and increasing clinical adoption of bioprinting for regenerative medicine.
Europe will see steady expansion, aided by university research funding and regulatory alignment for tissue engineering.
By 2035, bioprinting will shift from prototype development toward clinical-grade therapies that transform organ replacement and drug testing pathways.
To know more about the 3D Bioprinting Market - Download our Sample Report: https://marketgenics.co/download-report-sample/3d-bioprinting-market-for-tissue-organs-11103
Key Drivers, Challenges, and Opportunities
Driver - Rising Organ Transplant Demand
Chronic organ shortages and long wait times are accelerating the need for bioprinted tissues. Companies like CELLINK are already developing vascularized tissue constructs for transplantation research.
Restraint - High Cost of Bioprinters and Bioinks
The steep capital requirements of advanced bioprinters and expensive bioinks remain barriers. Hospitals, startups, and smaller labs face funding hurdles, limiting broader adoption.
Opportunity - Personalized Therapeutics and Reduced Animal Testing
Bioprinting offers the ability to create patient-specific tissues and organs, reducing immune rejection risks. It also provides human-relevant models for pharmaceutical and cosmetics testing, lowering reliance on animal studies.
Key Trend - Growing Preference for Inkjet-Based Bioprinting
Inkjet-based bioprinting holds the largest market share (~37%) due to its speed, precision, and lower cost compared to laser-based systems. Its non-contact process reduces contamination risk, making it particularly valuable for biomedical applications.
The ability to print delicate structures layer-by-layer has positioned inkjet platforms as the go-to technology for regenerative medicine, tissue engineering, and drug screening.
Buy Now: https://marketgenics.co/buy/3d-bioprinting-market-for-tissue-organs-11103
Segmental Insights
Technology - Inkjet Dominates
Inkjet-based systems lead with ~37% share in 2025, supported by their versatility in printing multi-material structures and precision placement of living cells.
Application - Drug Testing Expands
Pharmaceutical companies increasingly use bioprinted liver and skin models to accelerate toxicity and efficacy studies, reducing time-to-market for new therapies.
End-User - Research Institutions Lead
Universities, biotech firms, and medical research centers account for the largest adoption, supported by grants and collaborations in regenerative medicine.
Regional Highlights
North America: Leads global adoption, backed by NIH grants, biotech clusters, and collaborations involving Organovo, CELLINK, and Aspect Biosystems.
Asia-Pacific: Fastest-growing market, with emerging players like Pandorum Technologies exploring low-cost solutions for organ models.
Europe: Strong academic ecosystem with scaffold and biomaterial research driving adoption.
Middle East & Africa: Gradual uptake, with focus on university research and regenerative medicine pilots.
Competitive Landscape
The 3D bioprinting market for tissues and organs is moderately fragmented, with the top five players accounting for over 56% share in 2025.
Tier 1 Leaders:
Organovo
CELLINK (BICO Group)
3D Systems
Cyfuse Biomedical
Aspect Biosystems
Emerging Innovators:
Pandorum Technologies
TEVido BioDevices
Competition centers on bioink innovation, scaffold-free printing, and regulatory-grade applications that can accelerate commercialization.
Get a preview of our 3D Bioprinting Market Playbook - your guide to GTM strategy, competitive intelligence, supplier dynamics, and Consumer Behavior Analysis: https://marketgenics.co/playbook/3d-bioprinting-market-for-tissue-organs-11103
Future Outlook
By 2035, 3D bioprinting will evolve from research-driven applications into mainstream clinical solutions for organ replacement, regenerative therapies, and drug testing.
Key growth areas include:
Bioprinted organs for transplant-ready use
AI-optimized tissue design for faster maturation
Personalized therapeutics tailored to patient genetics
Ethical alternatives to animal testing
As funding accelerates and regulatory approvals expand, 3D bioprinting is set to become a cornerstone of healthcare innovation, addressing global organ shortages and redefining personalized medicine.
Prominent Companies Operating in the Global 3D Bioprinting Market for Tissues & Organs:
Organovo, CELLINK (BICO Group), 3D Systems, Cyfuse Biomedical, Aspect Biosystems, Pandorum Technologies, TEVido BioDevices, and other key players.
About Us
MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.
We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.
Contact:
Mr. Debashish Roy
MarketGenics India Pvt. Ltd.
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 3D Bioprinting Market for Tissues & Organs to Reach USD 6 Billion by 2035, Driven by Regenerative Medicine and Inkjet Bioprinting Advances here
News-ID: 4205339 • Views: …
More Releases from MarketGenics India Pvt. Ltd.
AI-Driven Precision Medicine Market to Reach USD 9.7 Billion by 2035, Powered by …
The global AI-Driven Precision Medicine Market is projected to expand from USD 0.7 billion in 2025 to USD 9.7 billion by 2035, registering a CAGR of 26.8% over the forecast period.
Rapid advances in machine-learning models for genomics and imaging, multi-omics analytics, and clinical-grade AI devices are enabling earlier detection, faster treatment matching, and workflow automation that together compress diagnostic timelines and improve therapeutic precision.
MarketGenics, a leading research firm, highlights…
Anti-Aging Products Market to Reach USD 112.3 Billion by 2035, Fueled by AI-Driv …
The global Anti-Aging Products Market is projected to grow from USD 51.7 billion in 2025 to USD 112.3 billion by 2035, expanding at a CAGR of 7.3% over the forecast period.
Growth is driven by rising demand for personalized skincare, clean-label and bioactive ingredients, and digital-first product models (AI diagnostics + D2C subscriptions) that improve engagement and lifetime value.
MarketGenics positions anti-aging solutions as a cross-sector growth engine-where cosmetics, supplements, diagnostics,…
Antifungal Drugs Market to Reach USD 21.2 Billion by 2035, Driven by Novel Class …
The global Antifungal Drugs Market is projected to grow from USD 14.3 billion in 2025 to approximately USD 21.2 billion by 2035, expanding at a CAGR of 4.0% over the forecast period.
This steady growth is being driven by the emergence of novel antifungal classes targeting resistant molds, the shift toward once-weekly and oral step-down regimens, and increasing integration of rapid diagnostics with therapeutic stewardship to improve outcomes and limit…
Bioelectric Toothbrush Market to Reach USD 2.1 Billion by 2035, Driven by Ionic …
The global Bioelectric Toothbrush Market is projected to grow from USD 0.7 billion in 2025 to USD 2.1 billion by 2035, expanding at a CAGR of 11.3% during the forecast period. Growth is powered by rising oral-health awareness, broader adoption of ionic and microcurrent technologies, and the integration of AI-guided brushing and app connectivity that together elevate routine hygiene into therapeutic, data-driven care.
MarketGenics, a specialist market research firm, positions bioelectric…
More Releases for Bioprinting
Prominent 4D Bioprinting Market Trend for 2025: Strategic Partnerships Drive Inn …
Which drivers are expected to have the greatest impact on the over the 4d bioprinting market's growth?
The surge in the need for organ transplants is anticipated to fuel the expansion of the 4D bioprinting market. Organ transplants entail the surgical removal of an organ or tissue from an individual (the donor) and transferring it to another person (the recipient) who requires the organ due to organ failure or disorder. Lifesaving…
3D Bioprinting Market: Research Methodology and Scope
The 3D Bioprinting Market size was valued at USD 1.39 Bn. in 2022 and the total revenue is expected to grow by 20.07% from 2023 to 2029, reaching nearly USD 5.01 Bn.
3D Bioprinting Market Market Report Scope and Research Methodology
Report Scope: The Maximize Market Research Pvt Ltd report offers an extensive examination of the global 3D Bioprinting Market, predicting its growth in terms of USD value from 203 to 2029.…
3D Bioprinting Market Growth Probability, Leading Vendors and Future Scenario Du …
An influential 3D Bioprinting Market report is the most suitable solution for the business requirements in many ways. The report aids in achieving an extreme sense of evolving industry movements before the competitors. The report also covers market overview, premium insights, key insights and company profiles in detail of the key market players. The best tools have been adopted to generate this report which is SWOT analysis and Porter’s…
3D Bioprinting Market: Future of Bioprinting, it is Creating Real Change in the …
The growth of the 3D bioprinting market is mainly driven by the technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities, especially in emerging markets, which are expected to witness the highest growth.
The 3D…
Bioprinting Global Market 2018: Key Players – 3D BIO CORP., 3D BIOPRINTING SOL …
Bioprinting Industry
Description
Wiseguyreports.Com Adds “Bioprinting -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database
3-D printers are beginning to revolutionize the manufacturing industry and are now increasingly used to make finished parts and goods. This industry is reshaping traditional supply chains and is enabling localization and customization in the manufacturing sector. Bioprinting is related to 3-D printing but uses living cells as well as…
3D Bioprinting market : Global Overview 2022
Research Trades adds a new report package “3D Bioprinting market- Size, Share, Trends, Forecast, Growth 2022”
In this report, the global 3D Bioprinting market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market…
